Apolipoprotein E 4 allele is associated with low bone density in postmenopausal women

Journal of Endocrinological Investigation

Volumn 26, Issue 4, 2003, Pages 312-315

  Zajickova K ^a   Zfkova I ^a   Hill, M ^a   Horinek A ^a   Novakova A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apolipoprotein E genotypes; Bone mineral density; Osteoporosis; Postmenopausal women

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E 4; APOLIPOPROTEIN E-4; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CALCIUM; OSTEOCALCIN; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIUM; VITAMIN K GROUP;

ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BONE DENSITY; BONE MASS; BONE METABOLISM; CALCIUM BLOOD LEVEL; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; GENE AMPLIFICATION; GENE FREQUENCY; GENETICS; GENOTYPE; HIP; HISTOLOGY; HOMEOSTASIS; HUMAN; INVOLUTIONAL BONE LOSS; LUMBAR SPINE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; METABOLISM; OSTEOLYSIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; RADIODENSITOMETRY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SPINE;

EID: 18144441742     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345178     Document Type: Article

References (23)

1. Pocock N.A., Eisman J.A., Hopper J.L., Yeats M.G., Sambrook P.N., Ebert S. Genetic determinants of bone mass in adults: A twin study. J. Clin. Invest. 1987, 80: 706-710.
2. Seeman E., Hopper J.L., Bach L.A., et al. Reduced bone mass in daughters of women with osteoporosis. N. Engl. J. Med. 1989, 320: 554-558.
3. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphisms and atherosclerosis. Arteriosclerosis 1988, 8: 1-21.
4. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993, 261: 921-923.
5. Shiraki M., Shiraki Y., Aoki Ch., et al. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 1997, 12: 1438-1445.
6. Mühlen D.G., Barrett-Connor E., Schneider D.L., Morin P.A., Parry P. Osteoporosis and apolipoprotein E genotype in older adults: The Rancho Bernardo Study. Osteoporos. Int. 2001, 12: 332-335.
7. Cauley J.A., Zmuda J.M., Yaffe K., et al. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures. J. Bone Miner. Res. 1999, 14: 1175-1181.
8. Salamone L.M., Cauley J.A., Zmuda J., et al. Apolipoprotein E gene polymorphism and bone loss: Estrogen status modifies the influence of apolipoprotein E on bone loss. J. Bone Miner. Res. 2000, 15: 308-314.
9. Vogt M.T., Cauley J.A., Kuller L.H., Nevitt M.C. Bone mineral density and blood flow to the lower extremities: The study of osteoporotic fractures. J. Bone Miner. Res. 1997, 12: 283-289.
10. Kiel D.P., Cupples L.A., Myers R.H., et al. Bone mineral density, hip fracture and apolipoprotein E genotype. Bone 1998, 23: S278.
11. Štulc T., Češka R., Hořínek A., Štěpán J. Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotype. Physiol. Res. 2000, 49: 435-439.
12. Heikinen A.M., Kroger H., Niskanen L., et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women? Maturitas 2000, 34: 33-41.
13. Miler S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acid. Res. 1988, 16: 1215.
14. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid. Res. 1990, 1: 545-548.
15. Crook R., Hardy J., Duff K. Single-day apolipoprotein E genotyping. J. Neurosci. Methods 1994, 53: 125-127.
16. Khoury A.M., Beaty T.H., Cohen B.H. Fundamental of Genetic Epidemiology. Oxford University Press, New York, 1993, p. 49-54.
17. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 1985, 37: 268-285.
18. Saupe J., Shearer M.J., Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am. J. Clin. Nutr. 1993, 58: 204-208.
19. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem. J. 1990, 266: 625-635.
20. Weisgraber K.H., Rall S. Jr., Mahley R.W. Human E apoprotein heterogenity: Cystein-arginine interchanges in the amino acid sequence of apo E isoforms. J. Biol. Chem. 1981, 256: 9077-9083.
21. Kohlmeier M., Salamon A., Saupe J., Shearer M. Transport of vitamin K to bone in humans. J. Nutr. 1996, 126: 1192-1196.
22. Kohlmeier M., Saupe J., Schaefer K., Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif. Tissue Int. 1998, 62: 278-281.
23. Beaven S.R., Prentice A., Stirling D.M. Apolipoprotein E (Apo E) genotype and osteocalcin carboxylation postmenopause. J. Bone Miner. Res. 1998, 13: 011 (abstract).